Please wait...
GulfBase Live Support
Leave a message and our representative will contact you soon
- Dubai listed companies buck wider declining GCC trend
- E& shareholders approve 83 fils dividend per share for FY 2024
- Tariffs: GCC banks face limited direct impact; oil prices key
- KACST to set up Quantum Valley with major firms
- Expat remittances from Saudi Arabia hit $3.4bn in February, a 37% annual growth
- Oil Updates - crude edges up on potential US tariff exemptions on cars
- Saudi inflation holds at 2.3% in March amid rising housing and food prices
- Saudi real estate prices rise 4.3% in Q1 on residential sector gains: GASTAT
- Dukhan Bank launches new House Finance campaign
- Doha Bank partners with Ox Fitness Lab
- AVALONPHARMA
- :131.2
- :128.8
- ('000):20,000
- ( '000):2,588,000
- :0
-
19,234 - :0
- :
- 18.20%
- 20.93%
-
475 -
():
2,501,445.2 - ():7,100,992
- :0.35
- Performance Comparison
- :Saudi Stock Exchange
- :Pharma, Biotech & Life Science
- :Small Cap
- :Health Care
Company Overview
- :29/06/1998
- :SAR 200,000,000
- :SAR 10
Activities
Middle East Pharmaceutical Industries Company is a prominent pharmaceutical company headquartered in Riyadh, Saudi Arabia. The company focuses on research, development, manufacturing, and marketing of generic medicines and pharmaceutical preparations. Their product portfolio includes treatments for various health conditions, such as: skin diseases, respiratory, central nervous, digestive, and musculoskeletal system disorders, urinary and reproductive system issues, diabetes, cardiovascular diseases, and anti-infective treatments, pain relief, antiseptics, and men's and women's health products. The company operates through three segments: Private, Public, and Export. Additionally, they offer contract manufacturing services and specialize in cosmetic, health products, and nutritional supplements. Formerly known as Middle East Chemical Products Factory Company, it changed its name to Middle East Pharmaceutical Industries Company in January 2006. The company also exports its products internationally, contributing to healthcare access beyond its home country.
-
Chairman:Ahmed S. A. Al-Tabbaa
-
Vice-chairman:Hisham M. M. Attar
-
CEO:Mohamed M. M. Al-Ghannam
-
General Manager:
-
Managing Director:
-
Board Members:
Faisal S. M. Al-Jaman
Mohammed M. Al-Ghannam
Omar M. S. Al-Jaroudi
-
Auditors:
KPMG Professional Consulting
CFO
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 23/03/2025 | 12-Month | 31/12/2024 | 80 | 21.3 |
| 07/11/2024 | 9-Month | 30/09/2024 | 35 | 0 |
| 06/08/2024 | 6-Month | 30/06/2024 | 31 | 77.63 |
| 19/05/2024 | 3-Month | 31/03/2024 | 09 | 0 |
| 25/03/2024 | 12-Month | 30/09/2023 | 66 | 10.73 |
- investor.relations@avalon.com.sa
- www.avalonpharmaceutical.com
- P.O. Box 3800 Riyadh 14331
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 26,415.48 | 284 | 0.28 | -2.58 | 44.52 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,105.51 | 2.73 | 1.86 | 0 | 26.51 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,793.69 | 88.9 | -0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 3,949.53 | 114.2 | 0.17 | -15.6 | 17.78 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 3,912.22 | 73.8 | 0.54 | -28.46 | 22.31 | 2.64 | 0 | 0.81 | 13.85 | 22.49 |
| DALLAHHEALTH | 3,337.3 | 127 | -0.94 | -5.63 | 26.59 | 4.66 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,905.92 | 46.75 | -0.54 | 0 | 40.5 | 0 | 0 | 0 | 0 | 0 |
| JAMJOOMPHARMA | 2,857.95 | 157.8 | 3 | 18.09 | 30.69 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,417.69 | 126 | -2.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NABAALSAHA | 1,933.59 | 66 | -4.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,790.49 | 146 | -2.54 | -16.19 | 24.48 | 6.96 | 0 | 0.85 | -0.59 | -0.89 |
| TIBBIYAH | 1,766.9 | 33.5 | 1.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,601.72 | 65.3 | 0 | -28.25 | 28.44 | 3.68 | 0 | 0.79 | 11.92 | 18.76 |
| QOMEL | 1,147.28 | 121 | -1.63 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PROMEDEX | 920.62 | 98 | -0.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 793.74 | 24.2 | -2.5 | -2.21 | 73.56 | 1.13 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 734.21 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 690.77 | 129.4 | -0.16 | 0 | 32.22 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 639.6 | 119 | -0.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 529.53 | 797 | 0 | -4.78 | 13.35 | 1.39 | 0 | 0 | 12.06 | 17.87 |
| AYYAN | 411.41 | 15.64 | 1.95 | -8.1 | -7.33 | 1.54 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 390 | 1.99 | -2.93 | 0 | 0 | 1.09 | 3 | -0.08 | 75.81 | 111.42 |
| JULPHAR | 377.34 | 1.19 | -0.84 | 0 | -60.3 | 0.58 | 5.27 | 0.2 | 4.09 | 0 |
| ATC.KW | 369.11 | 715 | -4.67 | 0 | 41.28 | 2.28 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 348.7 | 4.61 | 1.31 | -0.04 | 21.32 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 328.59 | 40.7 | -0.98 | 5.1 | 25.64 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 228.65 | 4.11 | -2.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 216.61 | 22.8 | 12.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 205.44 | 1.47 | 1.37 | 0 | 1.61 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 134.61 | 6.41 | -2.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 112.03 | 17.88 | 1.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 88.61 | 6.63 | -0.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 43.4 | 1.36 | -1.45 | 16.69 | -2.33 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 32.46 | 6 | -1.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 25.62 | 76.1 | -1.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 22.24 | 49.9 | -9.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 19.33 | 21.1 | -6.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia